Author Correction :: High p16 expression and heterozygous RB1 loss are biomarkers for CDK4/6 inhibitor resistance in ER + breast cancer

Marta Palafox; Laia Monserrat; Meritxell Bellet Ezquerra; Guillermo Villacampa Javierre; Abel Gonzalez-Perez; Mafalda Oliveira; Fara Brasó-Maristany; Nusaibah Ibrahimi; Srinivasaraghavan Kannan; Leonardo Mina; Maria Teresa Herrera-Abreu; Andreu Òdena; Mònica Sánchez-Guixé; Marta Capelán; Analía Azaro; Alejandra Bruna; Olga Rodríguez; Marta Guzmán; Judit Grueso; Cristina Viaplana; Javier Hernandez-Losa; Faye Su; Kui Lin; Robert B. Clarke; Carlos Caldas; Joaquín V Arribas; Stefan Michiels; Alicia García-Sanz; Nicholas C. Turner; Aleix Prat; Paolo Nuciforo; Rodrigo Dienstmann; Chandra S. Verma; Nuria Lopez-Bigas; Maurizio Scaltriti; Monica Arnedos; Cristina Saura Manich; Violeta Serra

doi:10.1038/s41467-022-34580-3

Author Correction : High p16 expression and heterozygous RB1 loss are biomarkers for CDK4/6 inhibitor resistance in ER + breast cancer

Marta Palafox, Laia Monserrat, Meritxell Bellet Ezquerra, Guillermo Villacampa Javierre, Abel Gonzalez-Perez, Mafalda Oliveira, Fara Brasó-Maristany, Nusaibah Ibrahimi, Srinivasaraghavan Kannan, Leonardo Mina, Maria Teresa Herrera-Abreu, Andreu Òdena, Mònica Sánchez-Guixé, Marta Capelán, Analía Azaro, Alejandra Bruna, Olga Rodríguez, Marta Guzmán, Judit Grueso, Cristina ViaplanaJavier Hernandez-Losa, Faye Su, Kui Lin, Robert B. Clarke, Carlos Caldas, Joaquín V Arribas, Stefan Michiels, Alicia García-Sanz, Nicholas C. Turner, Aleix Prat, Paolo Nuciforo, Rodrigo Dienstmann, Chandra S. Verma, Nuria Lopez-Bigas, Maurizio Scaltriti, Monica Arnedos, Cristina Saura Manich, Violeta Serra

Department of Medicine

Research output: Contribution to journal › Article › Research › peer-review

Original language	English
Journal	Nature Communications
Volume	13
DOIs	https://doi.org/10.1038/s41467-022-34580-3
Publication status	Published - 2022

Keywords

Breast cancer
Predictive markers
Cancer models

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1038/s41467-022-34580-3

https://ddd.uab.cat/record/268800

Cite this

Palafox, M., Monserrat, L., Bellet Ezquerra, M., Villacampa Javierre, G., Gonzalez-Perez, A., Oliveira, M., Brasó-Maristany, F., Ibrahimi, N., Kannan, S., Mina, L., Herrera-Abreu, M. T., Òdena, A., Sánchez-Guixé, M., Capelán, M., Azaro, A., Bruna, A., Rodríguez, O., Guzmán, M., Grueso, J., ... Serra, V. (2022). Author Correction : High p16 expression and heterozygous RB1 loss are biomarkers for CDK4/6 inhibitor resistance in ER + breast cancer. Nature Communications, 13. https://doi.org/10.1038/s41467-022-34580-3

@article{f47bdbe793b14f31a256b1008d3cf87c,

title = "Author Correction :: High p16 expression and heterozygous RB1 loss are biomarkers for CDK4/6 inhibitor resistance in ER + breast cancer",

keywords = "Breast cancer, Predictive markers, Cancer models",

author = "Marta Palafox and Laia Monserrat and {Bellet Ezquerra}, Meritxell and {Villacampa Javierre}, Guillermo and Abel Gonzalez-Perez and Mafalda Oliveira and Fara Bras{\'o}-Maristany and Nusaibah Ibrahimi and Srinivasaraghavan Kannan and Leonardo Mina and Herrera-Abreu, {Maria Teresa} and Andreu {\`O}dena and M{\`o}nica S{\'a}nchez-Guix{\'e} and Marta Capel{\'a}n and Anal{\'i}a Azaro and Alejandra Bruna and Olga Rodr{\'i}guez and Marta Guzm{\'a}n and Judit Grueso and Cristina Viaplana and Javier Hernandez-Losa and Faye Su and Kui Lin and Clarke, {Robert B.} and Carlos Caldas and Arribas, {Joaqu{\'i}n V} and Stefan Michiels and Alicia Garc{\'i}a-Sanz and Turner, {Nicholas C.} and Aleix Prat and Paolo Nuciforo and Rodrigo Dienstmann and Verma, {Chandra S.} and Nuria Lopez-Bigas and Maurizio Scaltriti and Monica Arnedos and {Saura Manich}, Cristina and Violeta Serra",

year = "2022",

doi = "10.1038/s41467-022-34580-3",

language = "English",

volume = "13",

}

Palafox, M, Monserrat, L, Bellet Ezquerra, M, Villacampa Javierre, G, Gonzalez-Perez, A, Oliveira, M, Brasó-Maristany, F, Ibrahimi, N, Kannan, S, Mina, L, Herrera-Abreu, MT, Òdena, A, Sánchez-Guixé, M, Capelán, M, Azaro, A, Bruna, A, Rodríguez, O, Guzmán, M, Grueso, J, Viaplana, C, Hernandez-Losa, J, Su, F, Lin, K, Clarke, RB, Caldas, C, Arribas, JV, Michiels, S, García-Sanz, A, Turner, NC, Prat, A, Nuciforo, P, Dienstmann, R, Verma, CS, Lopez-Bigas, N, Scaltriti, M, Arnedos, M, Saura Manich, C & Serra, V 2022, 'Author Correction : High p16 expression and heterozygous RB1 loss are biomarkers for CDK4/6 inhibitor resistance in ER + breast cancer', Nature Communications, vol. 13. https://doi.org/10.1038/s41467-022-34580-3

TY - JOUR

T1 - Author Correction :

T2 - High p16 expression and heterozygous RB1 loss are biomarkers for CDK4/6 inhibitor resistance in ER + breast cancer

AU - Palafox, Marta

AU - Monserrat, Laia

AU - Bellet Ezquerra, Meritxell

AU - Villacampa Javierre, Guillermo

AU - Gonzalez-Perez, Abel

AU - Oliveira, Mafalda

AU - Brasó-Maristany, Fara

AU - Ibrahimi, Nusaibah

AU - Kannan, Srinivasaraghavan

AU - Mina, Leonardo

AU - Herrera-Abreu, Maria Teresa

AU - Òdena, Andreu

AU - Sánchez-Guixé, Mònica

AU - Capelán, Marta

AU - Azaro, Analía

AU - Bruna, Alejandra

AU - Rodríguez, Olga

AU - Guzmán, Marta

AU - Grueso, Judit

AU - Viaplana, Cristina

AU - Hernandez-Losa, Javier

AU - Su, Faye

AU - Lin, Kui

AU - Clarke, Robert B.

AU - Caldas, Carlos

AU - Arribas, Joaquín V

AU - Michiels, Stefan

AU - García-Sanz, Alicia

AU - Turner, Nicholas C.

AU - Prat, Aleix

AU - Nuciforo, Paolo

AU - Dienstmann, Rodrigo

AU - Verma, Chandra S.

AU - Lopez-Bigas, Nuria

AU - Scaltriti, Maurizio

AU - Arnedos, Monica

AU - Saura Manich, Cristina

AU - Serra, Violeta

PY - 2022

Y1 - 2022

KW - Breast cancer

KW - Predictive markers

KW - Cancer models

U2 - 10.1038/s41467-022-34580-3

DO - 10.1038/s41467-022-34580-3

M3 - Article

C2 - 36376284

SN - 2041-1723

VL - 13

JO - Nature Communications

JF - Nature Communications

ER -